Please assess the completion status of the following clinical trial:

Trial Title: Detection of Borrelia Bacteria in Early Stage Lyme Borreliosis Using the T2Lyme Panel

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Presence of erythematous skin lesion, consistent with erythema migrans (EM).~* Age 18 or older.~* Ability to read, comprehend, and sign the informed consent form.~* Two (2) or more signs/symptoms of Lyme Disease~Exclusion Criteria:~* Subject has medically diagnosed bleeding disorder.~* Having had taken antibiotics in the past 30 days.~* EM located on face or neck.~* Unable to provide consent.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- EM present (Type: ACTIVE_COMPARATOR): All patients must display signs/symptoms of Lyme disease as well as exhibit an EM lesion.
- No EM present (Type: ACTIVE_COMPARATOR): All patients must display signs/symptoms of Lyme disease but do not have an EM lesion.

Based on this trial design, predict the completion outcome and termination type (if applicable).